清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clinical efficacy of Avène hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients

医学 水疗室 斯科拉德 特应性皮炎 银屑病 观察研究 银屑病面积及严重程度指数 皮肤病科 疾病严重程度 队列 物理疗法 内科学 皮肤科生活质量指数 病理 替代医学
作者
C Merial‐Kieny,X. Mengual,D. Guerrero,V. Sibaud
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:25 (s1): 30-34 被引量:44
标识
DOI:10.1111/j.1468-3083.2010.03900.x
摘要

Abstract Background Atopic dermatitis (AD) and psoriasis are chronic skin conditions. Local or systemic treatments are effective, but their effects are transient. Hydrotherapy, used alone or in combination with other treatments, could be considered as one form of care in providing effective management of these dermatoses. The objective of this observational study was to evaluate the benefit of a 3‐week treatment at Avène Hydrotherapy Centre in a very large cohort of patients suffering from atopic dermatitis and psoriasis and to assess the treatment benefits on patients undergoing hydrotherapy for two consecutive years. Methods This 8‐year observational study analysed 14 328 records of patients having a dermatological disease and who came to Avène Hydrotherapy Centre for a 3‐week treatment between 2001 and 2009. Among them, patients were suffering from atopic dermatitis ( n = 5916) and psoriasis ( n = 4887). On admission on D0 (day 0) and at the end of cure on D18 (day 18), the severity of AD and psoriasis were evaluated by SCORing Atopic Dermatitis (SCORAD) and Psoriasis Area and Severity Index (PASI), respectively. In order to assess the cumulative effect of the hydrotherapy treatment, the evolution of SCORAD or PASI of patients who came 2 years in a row was also calculated. Results A significant improvement in SCORAD was observed between D0 and D18 (−41.6%) ( P < 0.0001) and similarly, a significant reduction in PASI was noted between D0 and D18 (−54.4%) ( P < 0.0001) after 3‐weeks of hydrotherapy. PASI 50 and PASI 75 were 64.3% and 19.5%, respectively. For atopic patients ( n = 1102) or patients suffering from psoriasis ( n = 833) who came for two consecutive years, a significant SCORAD and PASI improvement was observed on D0 of the second year when compared with D0 of the previous year ( P < 0.0001). Conclusions This study is the first observational study in such a large cohort demonstrating the benefit of a 3‐week treatment at the Avène Hydrotherapy Centre for atopic and psoriatic patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助狮子座采纳,获得10
12秒前
26秒前
陆黑暗完成签到 ,获得积分10
29秒前
刘思琪发布了新的文献求助10
30秒前
Jasper应助刘思琪采纳,获得10
36秒前
刘思琪完成签到,获得积分20
42秒前
柒八染完成签到 ,获得积分10
54秒前
zzhui完成签到,获得积分10
2分钟前
rengar完成签到,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
4分钟前
zsmj23完成签到 ,获得积分0
4分钟前
ksiswl发布了新的文献求助10
5分钟前
和谐的夏岚完成签到 ,获得积分10
5分钟前
6分钟前
扑流萤发布了新的文献求助10
7分钟前
研友_nxw2xL完成签到,获得积分10
7分钟前
muriel完成签到,获得积分10
8分钟前
xx完成签到 ,获得积分10
8分钟前
吕lvlvlvlvlv完成签到,获得积分10
8分钟前
9分钟前
扑流萤发布了新的文献求助10
9分钟前
川藏客完成签到 ,获得积分10
9分钟前
科研通AI2S应助扑流萤采纳,获得10
9分钟前
科研通AI2S应助扑流萤采纳,获得10
9分钟前
energyharvester完成签到 ,获得积分10
10分钟前
科研菜鸡完成签到 ,获得积分10
10分钟前
10分钟前
楚楚完成签到,获得积分10
10分钟前
希望天下0贩的0应助zimo采纳,获得10
11分钟前
11分钟前
zimo发布了新的文献求助10
11分钟前
满城烟沙完成签到 ,获得积分10
11分钟前
rikka完成签到,获得积分20
12分钟前
友好寻琴完成签到 ,获得积分10
12分钟前
miyavi完成签到,获得积分10
13分钟前
orixero应助小鳄鱼夸夸采纳,获得10
15分钟前
15分钟前
15分钟前
gwbk完成签到,获得积分10
15分钟前
nuliguan完成签到 ,获得积分10
16分钟前
高分求助中
The late Devonian Standard Conodont Zonation 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3244770
求助须知:如何正确求助?哪些是违规求助? 2888417
关于积分的说明 8252858
捐赠科研通 2556875
什么是DOI,文献DOI怎么找? 1385454
科研通“疑难数据库(出版商)”最低求助积分说明 650161
邀请新用户注册赠送积分活动 626285